- NASP’s Comments on the Centers for Medicare and Medicaid Services’ (CMS) proposed regulation Jan 25, 2019 The National Association of Specialty Pharmacy (NASP) is pleased to represent the entire spectrum of the... read more
- Final Medicare Part D Rule and CY 2019 Call letter released Apr 03, 2018 CMS issued a final Medicare Part D Rule and Part D Call Letter for CY 2019... read more
- Health care groups calling on lawmakers to pass a Medicare package to restore funding for expired Medicare programs Feb 05, 2018 The National Association of Specialty Pharmacy offered its support of a letter sent to congressional leaders... read more
- NASP submits comments to CMS on Medicare Proposed Rule for Contract Year 2019 Jan 17, 2018 NASP represents an industry that focuses on providing high quality patient care first with additional emphasis... read more
- NASP’s comments to FTC’s Understanding Competition in Prescription Drug Markets: Entry and Supply Chain Dynamics Workshop Dec 12, 2017 NASP represents an industry that focuses on providing high quality patient care first with an added... read more
- Looking for Leadership from HHS Secretary Nominee Alex Azar on Requiring Transparency from Big PBMs and Reducing Specialty Medication Costs for Sick Seniors Nov 17, 2017 FOR IMMEDIATE RELEASE WASHINGTON, D.C. (November 16, 2017) – President Trump’s new nominee for Health and... read more
- Diverse Health Care Providers & Stakeholders Urge President Trump to Appoint Rep. Earl “Buddy” Carter to Commission on Containing Costs of Lifesaving Prescription Drugs Oct 26, 2017 FOR IMMEDIATE RELEASE View Press Release Coalition Commends Rep. Carter’s Record of Working to Enhance Clinical... read more
- Rep. Tom Suozzi (NY3) Visits Great Neck Oncology Pharmacy to Tour, Discuss, & Learn the Importance of Specialty Pharmacy for Cancer Patients & Caregivers Oct 24, 2017 FOR IMMEDIATE RELEASE New York (Oct. 19) – Today, Rep. Tom Suozzi (D – Long Island, Queens) met with... read more
- Ensuring Rebates and Discounts in Medicare Part D Help Reduce Patient OOP Costs Oct 05, 2017 Please click here for the final signed copy of the letter Rep. Buddy Carter championed and... read more
- National Association of Specialty Pharmacy Dismisses PBM-Funded Report Claiming Drug Cost Savings from Direct & Indirect Remuneration (DIR) Fees Aug 04, 2017 View Press Release DIR fees continue to inflate prescription drug costs for the sickest, most vulnerable... read more